flavanone has been researched along with Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
Lokhande, KB; Nagare, S; Swamy, KV | 1 |
Cui, JR; Du, GH; Fang, LH; Feng, XE; Li, QS; Shi, L | 1 |
Kasum, CM; Ross, JA | 1 |
2 review(s) available for flavanone and Neoplasms
Article | Year |
---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Dietary flavonoids: bioavailability, metabolic effects, and safety.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Biological Availability; Cardiovascular Diseases; Diet; Epidemiologic Studies; Estrogen Receptor Modulators; Flavanones; Flavonoids; Flavonols; Humans; Intestinal Absorption; Isoflavones; Neoplasms; Phenols; Polymers; Safety | 2002 |
2 other study(ies) available for flavanone and Neoplasms
Article | Year |
---|---|
Docking and simulation studies on cyclin D/CDK4 complex for targeting cell cycle arrest in cancer using flavanone and its congener.
Topics: Cell Cycle Checkpoints; Cyclin D; Cyclin-Dependent Kinase 4; Cyclins; Flavanones; Humans; Molecular Dynamics Simulation; Neoplasms | 2023 |
Synthesis and biological activity of flavanone derivatives.
Topics: Antineoplastic Agents; Atherosclerosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Endothelial Cells; Flavanones; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neoplasms; Protein-Tyrosine Kinases; Structure-Activity Relationship | 2010 |